Outcomes

Course Outcome (CO) statements for POC I 

(Revised: 30/07/2025)

After successful completion of the Pharmaceutical Organic Chemistry I Practical, the students will be able to:

CO1: Demonstrate safe handling and techniques for purification of organic compounds such as crystallization and distillation.

CO2: Determine physical constants such as melting point and boiling point of organic compounds with accuracy.
 

CO3: Perform systematic qualitative analysis of unknown organic compounds by identifying functional groups using chemical tests.
 

CO4: Record, interpret, and report experimental data methodically in a scientific manner.
 

CO5: Carry out simple organic synthesis experiments
 

Course Outcome (CO) statements for POC II 

(Revised: 01/04/2025)

After successful completion of the Pharmaceutical Organic Chemistry II Practical, the students will be able to:

CO1: Write the structure, name, and type of isomerism of organic compounds.

CO2: Write the reaction, name the reaction, and determine the orientation of reactions.

CO3: Account for the reactivity and stability of compounds.

CO4: Describe the chemistry of fats and oils.

CO5: Differentiate polynuclear organic compounds concerning their chemistry.

Course Outcome (CO) statements for Medicinal Chemistry III 

(Revised: 20/03/2025)

After successful completion of the Medicinal Chemistry III Practical, the students will be able to:

CO1: Understand the fundamental concepts of Medicinal Chemistry, including drug design, structure-activity relationships (SAR), and the chemistry of therapeutic agents.

CO2: Apply knowledge of various classes of antibiotics, including β-lactam antibiotics, aminoglycosides, tetracyclines, macrolides, and polypeptides, to understand their mechanism of action, metabolism, and adverse effects.

CO3: Analyze the chemical and pharmacological properties of anti-infective agents such as antimalarials, antimycobacterials, and antivirals, emphasizing their SAR, mechanism of action, and clinical significance.

CO4: Evaluate the role of antifungal, anti-protozoal, anthelmintic, and synthetic anti-infective agents, understanding their structure, mechanism, and resistance patterns.

CO5: Create an understanding of anti-neoplastic agents, including alkylating agents, antimetabolites, antibiotics, kinase inhibitors, and monoclonal antibodies, to explore their role in cancer treatment.

CO6: Develop an understanding of modern drug design principles, including quantitative structure-activity relationships (QSAR) and physicochemical parameters, to explore new therapeutic approaches.